About 100 reports

  • GLOBAL LIVE ATTENUATED INFLUENZA VACCINES MARKET
  • Market definition

About Influenza Vaccine Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes...

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus UK Limited
  • SEASONAL INFLUENZA & VACCINATION
  • 5.2 CANADA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets,...

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • RIDTS FOR INFLUENZA A
  • RIDTS FOR INFLUENZA B

About Rapid Influenza Diagnostic Tests RIDT is an antigen-based diagnostic test used for diagnosis of influenza virus infections in point-of-care (POC) settings. It employs lateral flow technique called immunochromatographic assays. RIDTs are available in the market in the form of a dipstick, card, and cassette. The instrument...

  • Influenza
  • World
  • Forecast
  • Alere Inc.
  • Quidel Corporation
  • INFLUENZA A
  • INFLUENZA C

About Influenza Diagnostics The global influenza diagnostics market is expected to grow at a moderate pace in the forecast period. The factors that are expected to drive the market in the forecast period includes endemic and pandemic outburst of influenza disease, new strains and lineages in the viruses due to genetic modification...

  • Influenza
  • World
  • Alere Inc.
  • bioMerieux S.A.
  • Quidel Corporation
  • 5.15 AUSTRALIA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 5.2 CANADA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2022. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness...

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • INFLUENZA SYMPTOMS
  • SEASONAL INFLUENZA VACCINES MARKET

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025 Summary Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The infection’s rapid onset and potential for high morbidity and...

  • Influenza
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation
  • Influenza Drugs
  • France Influenza Market Overview

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent),...

  • Influenza
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.
  • 4.2 CANADA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 7.5 INCREASING AWARENESS ON SEASONAL INFLUENZA & VACCINATION

The influenza vaccines market in Americas is anticipated to reach nearly US$ 3 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly...

  • Influenza
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • TYPES OF INFLUENZA
  • 1.1 INFLUENZA

Influenza, also known as flu, is a contagious disease which spreads from person to person very rapidly. When an infected person sneezes or coughs the virus spreads to those close by, affecting immuno-compromised patients the most. The influenza virus is broadly classified as influenza A, influenza B, and influenza C. The influenza vaccine...

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • 7.5 INCREASING AWARENESS ON SEASONAL INFLUENZA & VACCINATION
  • 4.1 GERMANY - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly...

  • Influenza
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • Symptoms of Influenza
  • Available Antiviral Drugs for Seasonal Influenza

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Summary Seasonal influenza is a viral disease caused by influenza virus that spreads easily from person to person. Seasonal influenza is characterized by a...

  • Influenza
  • World
  • Market Size
  • Daiichi Sankyo Company
  • Sanofi S.A.
  • COLD AND FLU DRUGS
  • Cold and Flu Drugs Sales Volume

China’s demand for Cold and Flu Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Influenza
  • China
  • Sanshine Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • 2.2 ASIA AND AUSTRALASIA - NUMBER OF PERSONS VACCINATED WITH INFLUENZA
  • 4.10 AUSTRALIA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

The Asia and Australasia influenza vaccines market is anticipated to reach nearly US$ 1.5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together...

  • Influenza
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • Cold and Flu Drugs Sales Volume by Price
  • Cold and Flu Drugs Sales Volume Drugs Classification

This study focuses on China’s Cold and Flu Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Influenza
  • China
  • Demand
  • Sanshine Pharmaceutical Co., Ltd.
  • Shineway Pharmaceutical Co., Ltd.
  • 7.5 INCREASING AWARENESS ON SEASONAL INFLUENZA & VACCINATION
  • 4.5 GERMANY - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

The influenza vaccine is one of the most lucrative segment of the global vaccines market. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly...

  • Influenza
  • Forecast
  • Market Size
  • Novartis AG
  • Sanofi S.A.

Influenza Market, by Segment, Through 2022 Table ## : European Influenza Market, by Segment, Through 2022 Table ## : Approved WHO Influenza Centers, by Region Table ## : Abbreviations Used in Influenza Markets Table ## : Glossary of Terms Used in

  • Influenza
  • Therapy
  • Vaccine
  • World
  • 3. Structure of Influenza Virus
  • Notable Influenza Pandemics

Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza...

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • COLD AND FLU DRUGS
  • Cold and Flu Drugs Sales Volume

This study focuses on China’s Cold and Flu Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Influenza
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Sanshine Pharmaceutical Co., Ltd.
  • Shineway Pharmaceutical Co., Ltd.

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Compet

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Compet

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand
  • 2. Influenza - Introduction
  • Structure of Influenza Virus

Europe Influenza Vaccine Market was close to US$ 1 Billion. United Kingdom holds the highest seasonal influenza vaccine market share. United Kingdom, Germany, France, Italy & Spain together holds more than 80 percent of influenza vaccine market share. In children vaccine market, United Kingdom is the leader and France holds the second spot....

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market

Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast is report published by Renub Research. According to this report, in the Southern European countries, Italy is having the highest seasonal influenza vaccine market share followed by Spain. In terms of children vaccination, Italy & Spain holds...

  • Influenza
  • Vaccine
  • Southern Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market

Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close...

  • Influenza
  • Vaccine
  • Western Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market

Nordics Seasonal Influenza Vaccine Market in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination Forecast report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market...

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • 3. Eastern Europe Countries Seasonal Influenza

Romania is having the highest seasonal influenza vaccine market share in East Europe Countries. In terms of children vaccination, Romania & Hungary together accounts for more than 40 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 80 percent market share by 2022. Seasonal Influenza...

  • Influenza
  • Vaccine
  • Eastern Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market

Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania...

  • Healthcare
  • Influenza
  • Baltics
  • Northern Europe
  • Market Size
  • Risk Factors and Comorbidities for Seasonal Influenza
  • 2.3.2 Laboratory Confirmed Influenza Cases

EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025 Summary Influenza, commonly known as “the flu,” is a contagious respiratory illness caused by influenza viruses resulting in mild to severe “influenza–like” illness. Some of the serious outcomes of influenza infection could result in hospitalization or...

  • Influenza
  • Germany
  • Japan
  • United States
  • Forecast
  • Previous Flu Seasons in the United States
  • Americans' attitudes towards the flu vaccination

Seasonal influenza has a significant impact on sales of cough, cold and allergy products, particularly in years when the influenza vaccine is less effective. Consumers turn to a number of products during the flu season, including vitamins and dietary supplements for prevention, combination CCAs and nasal sprays for fevers and...

  • Influenza
  • Vaccine
  • United States
  • Demand
  • Mondelez International, Inc.

Influenza Diagnostic Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Influenza
  • APAC
  • World
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Europe
  • Japan
  • United States
  • Demand